Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Pyron** is an Izotop sterile lyophilized cold kit containing sodium pyrophosphate for in-situ preparation of technetium-99m pyrophosphate injection with sodium pertechnetate Tc-99m. The resulting diagnostic SPECT radiopharmaceutical localizes at sites of altered mineralization and is used for bone scintigraphy, imaging of acute myocardial infarction, blood-pool scintigraphy, and spleen scintigraphy. The non-radioactive Pyron kit can also be used to pretreat red blood cells before subsequent Tc-99m-pertechnetate administration for in-vivo red-blood-cell labeling. ([izotop.hu](https://www.izotop.hu/wp-content/uploads/PYRON_SPC_PIL_en_20151007.pdf))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pyron.